Skip to content

CDR

Walgreens kicks off Red Nose Day campaign

Walgreens kicks off Red Nose Day campaign

Walgreens stores nationwide have begun selling red noses in support of Red Nose Day, which runs from April 17 to May 30. Created in the United Kingdom, Red Nose Day brings people together every two years to do something funny to raise money for charity. To start the first Red Nose Day

London Drugs pilots oral cancer screenings

London Drugs pilots oral cancer screenings

London Drugs has partnered with LED Dental Inc. in a pilot program to provide free oral cancer screenings. In the pilot, LED Dental is providing its VELscope Vx Enhanced Oral Assessment System for screenings at 12 London Drugs pharmacies in the lower mainland area of British Columbia.

PhRMA chief executive Castellani to retire

PhRMA chief executive Castellani to retire

John Castellani, president and chief executive officer of Pharmaceutical Research and Manufacturers of America (PhRMA), plans to retire next year. PhRMA said Thursday that Castellani’s retirement is slated to go into effect Jan. 1, 2016.

Sandoz cleared to market Copaxone generic

Sandoz has received Food and Drug Administration approval for Glatopa, a treatment for multiple sclerosis (MS). The Novartis subsidiary said Thursday that its product is the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20 mg/ml once-daily MS therapy.

NBTY bolsters senior management team

NBTY bolsters senior management team

NBTY Inc. has appointed four senior executives to its management team, who will be charged with spearheading growth initiatives for the nutritional supplement maker and marketer’s branded businesses. NBTY said Thursday that Andre Branch has joined the company as chief marketing officer.

WBA sees ‘a significant opportunity’ ahead

WBA sees ‘a significant opportunity’ ahead

Walgreens Boots Alliance Inc. has the size and scope to be “one of the companies that helps shape the future of health care, pharmacy and retail on a global basis,” executive vice president and acting chief executive officer Stefano Pessina said at the company’s Analyst Day event.

Takeda U.S.A. names president

Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda.

London Drugs to sell personal drone

London Drugs to sell personal drone

London Drugs stores already boast a unique product mix with their substantial consumer-electronics departments, which feature products ranging from digital cameras and flat-screen TVs to computers and mobile devices. Yet now the retailer is adding another twist: a drone.

Walgreens aims to up the ante in pharmacy

Walgreens aims to up the ante in pharmacy

Walgreen Co. is revamping its customer experience and cutting costs to recapture its position as America’s “most loved” pharmacy, chain president Alex Gourlay told analysts at the first Walgreens Boots Alliance Analyst Day event here. “The reality is we’re no longer No. 1 in pharmacy volume.

Hi-Tech to acquire Latin America OTC, supplements supplier

Hi-Tech Pharmaceuticals plans to buy Advanced Pharmaceuticals and Nutritionals (APN), a leading supplier of over-the-counter health care products and dietary supplements in the Mexican, Central American, and South American markets. Financial terms of the agreement weren’t disclosed.

U.S. drug spending, scripts reach new highs

U.S. drug spending, scripts reach new highs

Specialty medications helped drive a double-digit gain in total spending on medicines in the United States for 2014, as well as record volume in prescriptions dispensed, according to the IMS Institute for Healthcare Informatics, a unit of IMS Health. Last year, U.S. spending on medicines rose 10.